Document is current
Any future updates will be listed below
-
Authors
Al-Shymali, Olena
McAlinden, Colm
Alio del Barrio, Jorge L.
Canto-Cerdan, Mario
Alio, Jorge L. https://orcid.org/0000-0002-8082-1751
-
Funding
Funding for this research was provided by:
instituto de salud carlos iii (RD16/0008/0012)
- License Information
-
More Information
Article History
Received: 19 July 2021
Accepted: 8 February 2022
First Online: 1 March 2022
Declarations
:
: Ethical Board Committee (Comite Etico de Investigacion Medica Instituto de Microgirurgia Ocular Ref number: 210321–167) approval was obtained for the purpose of this investigation.
: All individuals involved in this study gave their consent for the publication of the manuscript.
: Jorge L. Alio: Akkolens (C,S); Carl Zeiss Meditec (S,C); CSO (S); Hanita Lenses (C,S); Ophthec (L); Tekia (O); Associate editor of Eye and Vision; C = Consultant/advisor; E = Employee; L = Lecture fees; O = Equity owner; P = Patents/royalty; S = Clinical research grant. Colm McAlinden: Consultancy: Alcon, ClarVista, Ophtec, Acufocus, STAAR Surgical, RxSight, Bausch and Lomb, Perfect lens, Power Vision, Zeiss, Sight Glass Vision, CORD LLC, Ora, targomed GmbH, LensGen, PhysIOL, Ocudyne, Schwind; Travel: Thea, Bayer, Allergan; Editorial board member of Eye and Vision. Jorge L. Alió del Barrio: None. Olena Al-Shymali: None. Mario Canto-Cerdan: None.
